ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,661Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 53

$948K Total Retail Price of All Prescriptions

Rank: 11 out of 53

360 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,376 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $123 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 533 406 1 1
HYDROCODONE-ACETAMINOPHEN 526 398 S3 2 15
LOSARTAN POTASSIUM 361 291 3 27
SIMVASTATIN 354 291 4 6
OMEPRAZOLE 350 285 5 24
LISINOPRIL 346 211 6 8
FUROSEMIDE 280 184 7 16
GLIMEPIRIDE 262 197 8 10
JANUVIA 238 150 9 14
AMLODIPINE BESYLATE 236 211 10 18
GABAPENTIN 212 118 11 21
ZOLPIDEM TARTRATE 191 120 12 48
METOPROLOL SUCCINATE 188 162 13 34
POTASSIUM CHLORIDE 180 148 14 30
PRAVASTATIN SODIUM 176 145 15 17
ATORVASTATIN CALCIUM 175 128 16 12
ATENOLOL 167 124 17 54
CITALOPRAM HBR 162 101 18 58
DONEPEZIL HCL 145 140 19 92
INSULIN SYRINGE 140 63 20 9
METOPROLOL TARTRATE 137 104 21 26
TRAMADOL HCL 134 114 22 71
CLOPIDOGREL 132 98 23 66
METFORMIN HCL 129 105 24 3
BUSPIRONE HCL 126 65 25 94
LEVEMIR 112 48 26 42
HUMALOG MIX 75-25 112 81 26 36
NITROGLYCERIN PATCH 111 99 28 129
FOSINOPRIL SODIUM 111 85 28 129
CRESTOR 111 53 28 20
NEXIUM 110 100 31 35
METFORMIN HCL ER 110 71 31 22
WARFARIN SODIUM 110 82 31 64
NOVOLOG 108 58 34 19
PLAVIX 106 100 35 65
SYNTHROID 102 79 36 2
CARVEDILOL 99 69 37 61
PEN NEEDLE 98 57 38 4
LOSARTAN-HYDROCHLOROTHIAZIDE 98 85 38 56
HYDROCHLOROTHIAZIDE 97 86 40 28
SERTRALINE HCL 97 84 40 63
DOXAZOSIN MESYLATE 96 81 42 112
NOVOLOG MIX 70-30 95 71 43 47
BENAZEPRIL HCL 94 78 44 115
LEVEMIR FLEXPEN 94 56 44 23
ALLOPURINOL 91 78 46 51
POLYETHYLENE GLYCOL 3350 88 77 47 89
SINGULAIR 87 84 48 111
NOVOLOG MIX 70-30 FLEXPEN 74 47 49 33
MELOXICAM 73 43 50 98
AZITHROMYCIN 70 45 51 86
NOVOLOG FLEXPEN 70 35 51 13
KLOR-CON M20 69 55 53 82
LANSOPRAZOLE 68 37 54 160
PROPRANOLOL HCL 65 57 55 163
BUMETANIDE 63 49 56 126
ALENDRONATE SODIUM 61 49 57 44
LANTUS 59 34 58 7
COMBIVENT 59 48 58 102
DILTIAZEM 24HR CD 56 56 60 127
FENOFIBRATE 56 47 60 29
ESCITALOPRAM OXALATE 56 47 60 123
MONTELUKAST SODIUM 55 45 63 174
HUMALOG 54 21 64 11
LYRICA 54 54 64 88
CEPHALEXIN 53 37 66 132
ZETIA 52 52 67 32
ISOSORBIDE MONONITRATE ER 51 39 68 100
NAMENDA 51 51 68 94
EXELON 50 50 70 180
TRAZODONE HCL 50 44 70 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.